Nemaura Announces Successful Interim Results for SugarBEAT® European Clinical Trials

World News: . []

Nemaura Medical Inc OTCQB NMRD a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless adhesive skin-patch for adjunctive use by diabetics as a non-invasive and needle -free g...

More news and information about Nemaura Medical Inc.

Published By:

Business Wire: 14:00 GMT Thursday 21st September 2017

Published: .

Search for other references to "nemaura" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us